Endovascular Graft Systems: Letter to Health Care Providers - Type III Endoleaks Associated with Use
Date of publication: 28-09-2017
Type III endoleak may require treatment with additional interventions such as re-lining, insertion of additional endograft components, or open surgical repair. Interventions to address endoleaks carry added risks for impacted patients. Źródło: https://www.fda.gov
